Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sambazon is a leading global consumer brand specializing in organic, ethically sourced Açaí-based products. Founded in 2000, the company pioneered the introduction of Açaí to the global market, offering a range of frozen pulps, juices, energy drinks, and sorbets. The company operates on a triple bottom line business model, focusing on social, environmental, and economic success through sustainable harvesting in the Brazilian Amazon. While not a biotechnology or pharmaceutical firm, Sambazon is a major player in the health and wellness sector, emphasizing the nutritional benefits of antioxidants and healthy omegas. The company maintains a vertically integrated supply chain, ensuring quality from the palm trees in the rainforest to the final consumer product. Sambazon's products are widely distributed in major retail chains and food service outlets across North America and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sambazon.